-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ereua+pxFdhuUNOGaLhygIMCjHCAhPnFqmjKUIAqx8NXdqkDgFLSSCncoecbmKMt Yn84Lg1SCrT3iO6Bg/caSw== 0000894189-05-001446.txt : 20050611 0000894189-05-001446.hdr.sgml : 20050611 20050531133623 ACCESSION NUMBER: 0000894189-05-001446 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050331 FILED AS OF DATE: 20050531 DATE AS OF CHANGE: 20050531 EFFECTIVENESS DATE: 20050531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADVISORS SERIES TRUST CENTRAL INDEX KEY: 0001027596 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-07959 FILM NUMBER: 05866533 BUSINESS ADDRESS: STREET 1: U.S BANCORP FUND SERVICES, LLC STREET 2: 615 E MICHIGAN STREET CITY: MILWAUKEE STATE: WI ZIP: 53202 BUSINESS PHONE: 414-765-5344 MAIL ADDRESS: STREET 1: 615 E MICHIGAN STREET STREET 2: MK-WI-LC2 CITY: MILWAUKEE STATE: WI ZIP: 53202 N-Q 1 capitoladvisorsnq.htm QUARTERLY NOTICE OF PORFOLIO HOLDINGS Quarterly Notice of Porfolio Holdings
AS filed with the Securities and Exchnage Commission on May 31,  2005



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


 
FORM N-Q
 
 
QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY
 




Investment Company Act file number 811-07959



Advisors Series Trust
(Exact name of registrant as specified in charter)



615 E. Michigan St.
Milwaukee, WI 53202 
(Address of principal executive offices) (Zip code)



Eric M. Banhazl
Advisors Series Trust
2020 East Financial Way, Suite 100
Glendora, CA 91741
(Name and address of agent for service)



(414) 765-5340
Registrant's telephone number, including area code



Date of fiscal year end: December 31, 2005



Date of reporting period: March 31, 2005 







 
Item 1. Schedule of Investments.
 
 

Capital Advisors Growth Fund
     
           
Schedule of Investments
       
           
at March 31, 2005 (Unaudited)
     
           
SHARES
 
COMMON STOCKS - 99.2%
 
MARKET VALUE
   
Aerospace & Defense - 7.7%
   
11,500
 
Empresa Brasileira de Aeronautica SA ADR*
$
359,950
11,300
 
L-3 Communications Holdings, Inc.
 
802,526
         
1,162,476
   
Beverages - 6.3%
     
12,200
 
Constellation Brands, Inc. - Class A*
 
645,014
6,000
 
PepsiCo, Inc.
   
318,180
         
963,194
   
Biotechnology - 6.1%
     
9,900
 
Amgen, Inc.*
   
576,279
10,000
 
Biogen Idec, Inc.*
   
345,100
         
921,379
   
Communications Equipment - 13.6%
   
38,990
 
Avaya, Inc.*
   
455,403
19,000
 
Cisco Systems, Inc.*
   
339,910
17,790
 
QUALCOMM, Inc.
   
652,003
8,025
 
Research In Motion Ltd.*#
 
613,271
         
2,060,587
   
Computers & Peripherals - 2.3%
   
9,000
 
Dell, Inc.*
   
345,780
   
Diversified Financial Services - 1.9%
   
1,500
 
Chicago Mercantile Exchange Holdings, Inc.
 
291,045
   
Electronic Equipment & Instruments - 2.8%
   
7,500
 
CDW Corp.
   
425,100
   
Food Products - 1.9%
     
4,500
 
Wm. Wrigley Jr. Co.
   
295,065
   
Health Care Equipment & Supplies - 2.7%
   
8,000
 
Medtronic, Inc.
   
407,600
   
Internet & Catalog Retail - 4.5%
   
7,175
 
Amazon.Com, Inc.*
   
245,888
11,800
 
eBay, Inc.*
   
439,668
         
685,556
   
IT Services - 2.5%
     
9,300
 
CheckFree Corp.*
   
379,068
   
Media - 5.9%
     
11,600
 
Comcast Corp. - Class A*
 
391,848
16,000
 
XM Satellite Radio Holdings, Inc. - Class A*
 
504,000
         
895,848
   
Multiline Retail - 3.6%
     
10,000
 
Nordstrom, Inc.
   
553,800
   
Oil & Gas - 17.4%
     
10,500
 
Anadarko Petroleum Corp.
 
799,050
13,500
 
Apache Corp.
   
826,605
2,800
 
ConocoPhillips
   
301,952
18,000
 
Suncor Energy, Inc.#
   
723,780
         
2,651,387
   
Pharmaceuticals - 7.2%
   
6,000
 
American Pharmaceutical Partners, Inc.*
 
310,440
9,340
 
Novartis AG ADR
   
436,925
8,300
 
Sanofi-Aventis ADR
   
351,422
         
1,098,787
   
Semiconductor & Semiconductor Equipment - 6.5%
   
19,000
 
Intel Corp.
   
441,370
36,500
 
Omnivision Technologies, Inc.*
 
552,975
         
994,345
   
Software - 2.3%
     
14,160
 
Microsoft Corp.
 
$
342,247
   
Specialty Retail - 4.0%
     
11,200
 
Best Buy Co., Inc.
   
604,912
           
   
TOTAL COMMON STOCKS (Cost $13,726,086)
 
15,078,176
           
   
SHORT TERM INVESTMENTS - 0.7%
   
   
Investment Companies - 0.7%
   
111,477
 
SEI Daily Income Trust Government Fund - Class B
 
111,477
           
   
TOTAL SHORT TERM INVESTMENTS (Cost $111,477)
 
111,477
   
Total Investments (Cost $13,837,563) - 99.9%
 
15,189,653
   
Assets in Excess of Other Liabilities - 0.1%
 
16,614
   
TOTAL NET ASSETS - 100.0%
$
15,206,267
           
           
ADR -
American Depository Receipt
   
*
Non-income producing security.
   
#
U.S. security of foreign issuer.
   
 
For certain federal income tax information, as well as other information regarding securities valuation and other significant accounting policies, please refer to the footnotes to the Fund’s most recent semi-annual or annual report.]

 
Item 2. Controls and Procedures.
 
(a)  
The Registrant’s President/Chief Executive Officer and Treasurer/Chief Financial Officer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “1940 Act”)) are effective as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rules 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b)  
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the Act) that occurred during the Registrant's last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.


 
Item 3. Exhibits.
 
Separate certifications for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)). Filed herewith.
 
 
 


 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


(Registrant) Advisors Series Trust    

By (Signature and Title) /s/ Eric M. Banhazl 
                                                 Eric M. Banhazl, President
Date  5/26/05       

               Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)*  /s/ Eric M. Banhazl
                                                    Eric M. Banhazl, President
                Date 5/26/05
 
By (Signature and Title)* /s/ Douglas G. Hess 
                                                   Douglas G. Hess, Treasurer
                Date 5/31/05

* Print the name and title of each signing officer under his or her signature.

EX-99.CERT 2 certs.htm CERTIFICATION certification

 
CERTIFICATION
 
I, Eric M. Banhazl, certify that:

1.  
I have reviewed this report on Form N-Q of Advisors Series Trust;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: 5/26/05
/s/ Eric M. Banhazl
 
[Signature]
President



 
CERTIFICATION
 
I, Douglas G. Hess, certify that:

1.  
I have reviewed this report on Form N-Q of Advisors Series Trust;

2.  
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.  
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

4.  
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)  
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)  
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)  
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

(d)  
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.  
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)  
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

(b)  
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: 5/31/05
/s/ Douglas G. Hess
 
[Signature]
Treasurer
-----END PRIVACY-ENHANCED MESSAGE-----